Concepedia

Dan A. Rock

DA

Statistics

Publications

54

Citations

2.5K

H-Index

31

Active since

2001

Affiliations

Amgen (United States)(Current)

Washington State University

University of Washington

Pfizer (United States)

University of Minnesota

Dan A. Rock is an author at Amgen (United States) specializing in pharmacology, cytochrome p450 enzymes, and cytochrome p450-mediated metabolism.

Publications per year

2001–2022

54

Publications

54

Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture

Leslie J. Dickmann, Sonal Patel, Dan A. Rock et al. · Drug Metabolism and Disposition · 2011 · 190 citations

, , +16

SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

Kevin J. Hamblett, Allison P. Jacob, Jesse L. Gurgel et al. · Cancer Research · 2015 · 135 citations

, , +17

Alternative Splicing Determines the Function of CYP4F3 by Switching Substrate Specificity

Peter Christmas, Jeffrey P. Jones, Christopher Patten et al. · Journal of Biological Chemistry · 2001 · 132 citations · Full text

, , +13

CYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition Profiles

Vikas Kumar, Jan L. Wahlstrom, Dan A. Rock et al. · Drug Metabolism and Disposition · 2006 · 132 citations

, , +16

Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation

R. Foti, Dan A. Rock, Larry C. Wienkers et al. · Drug Metabolism and Disposition · 2010 · 130 citations

, , +17

1–5 of 54